Published in Child Adolesc Psychopharmacol News on April 01, 2014
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci (2000) 9.12
Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA (2002) 4.72
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci (1996) 3.33
Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry (2006) 3.17
Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology (2002) 2.64
Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev (2012) 2.54
National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry (2012) 2.52
Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci (2004) 2.42
Brain development and ADHD. Clin Psychol Rev (2006) 2.28
The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci (2003) 2.28
Enhancement of hippocampal neurogenesis by lithium. J Neurochem (2000) 2.28
Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci (2004) 2.17
Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorder. Am J Psychiatry (2010) 2.13
The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem (1999) 2.04
Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry (2005) 1.87
Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2001) 1.84
Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (1999) 1.78
Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry (2011) 1.69
Effects of medication on neuroimaging findings in bipolar disorder: an updated review. Bipolar Disord (2012) 1.53
Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand (2011) 1.48
Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry (2003) 1.46
Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS One (2010) 1.36
Relation between amygdala structure and function in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2009) 1.33
Volumetric MRI differences in treatment-naïve vs chronically treated children with ADHD. Neurology (2006) 1.21
Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings. Neuropsychopharmacology (2004) 1.20
Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology (Berl) (2007) 1.17
Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr Opin Pharmacol (2006) 1.16
Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry (2000) 1.16
Diagnostic and sex effects on limbic volumes in early-onset bipolar disorder and schizophrenia. Schizophr Bull (2007) 1.15
A magnetic resonance imaging study of the cerebellar vermis in chronically treated and treatment-naïve children with attention-deficit/hyperactivity disorder combined type. Biol Psychiatry (2009) 1.11
Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr Res (2006) 1.07
Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions. Biol Psychiatry (2005) 1.07
Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry (1998) 1.06
Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress. J Neurosci Res (2007) 1.06
Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex. Int J Neuropsychopharmacol (2005) 1.05
Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry (2012) 1.02
Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry (1996) 1.00
Subgenual prefrontal cortex of child and adolescent bipolar patients: a morphometric magnetic resonance imaging study. Psychiatry Res (2005) 0.99
Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder. Int J Dev Neurosci (2010) 0.98
Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways. J Mol Neurosci (2005) 0.97
Amphetamine induces dendritic growth in ventral tegmental area dopaminergic neurons in vivo via basic fibroblast growth factor. Neuroscience (2005) 0.97
Intracellular signaling pathways pave roads to recovery for mood disorders. Ann Med (2007) 0.95
The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci (2009) 0.95
Anterior cingulate volume in pediatric bipolar disorder and autism. J Affect Disord (2007) 0.94
Can a therapeutic dose of amphetamine during pre-adolescence modify the pattern of synaptic organization in the brain? Eur J Neurosci (2003) 0.93
Decrease in temporal gyrus gray matter volume in first-episode, early onset schizophrenia: an MRI study. PLoS One (2012) 0.93
Anatomic brain magnetic resonance imaging of the basal ganglia in pediatric bipolar disorder. J Affect Disord (2007) 0.91
Effects of ADHD therapeutic agents, methylphenidate and atomoxetine, on hippocampal neurogenesis in the adolescent mouse dentate gyrus. Neurosci Lett (2012) 0.91
Methylphenidate treatment recovers stress-induced elevated dendritic spine densities in the rodent dorsal anterior cingulate cortex. Dev Neurobiol (2007) 0.88
Update on amphetamine neurotoxicity and its relevance to the treatment of ADHD. J Atten Disord (2007) 0.88
Pediatric psychopharmacology: too much or too little? World Psychiatry (2013) 0.87
Fluoxetine upregulates phosphorylated-AKT and phosphorylated-ERK1/2 proteins in neural stem cells: evidence for a crosstalk between AKT and ERK1/2 pathways. J Mol Neurosci (2012) 0.85
The neural effects of psychotropic medications in children and adolescents. Child Adolesc Psychiatr Clin N Am (2012) 0.84
Antipsychotic-associated neuronal changes in the brain: toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.82
Age-related changes in the corpus callosum in early-onset bipolar disorder assessed using volumetric and cross-sectional measurements. Brain Imaging Behav (2010) 0.80
Increased subgenual cingulate cortex volume in pediatric bipolar disorder associated with mood stabilizer exposure. J Child Adolesc Psychopharmacol (2011) 0.80
Volumetric MRI differences in treatment naïve and chronically treated adolescents with ADHD-combined type. J Atten Disord (2012) 0.80
Chronic D-amphetamine administered from childhood to adulthood dose-dependently increases the survival of new neurons in the hippocampus of male C57BL/6J mice. Neuroscience (2012) 0.78
Morphology of the subgenual prefrontal cortex in pediatric bipolar disorder. J Psychiatr Res (2010) 0.78
Increased hippocampal volumes in lithium treated adolescents with bipolar disorders: a structural MRI study. J Affect Disord (2012) 0.77
Effects of age, sex, and independent life events on amygdala and nucleus accumbens volumes in child bipolar I disorder. Biol Psychiatry (2008) 0.76
Latent class profiles of depressive symptoms from early to middle childhood: predictors, outcomes, and gender effects. J Child Psychol Psychiatry (2016) 0.76
Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder. Bipolar Disord (2015) 0.75
Comorbid sleep disorders and suicide risk among children and adolescents with bipolar disorder. J Psychiatr Res (2017) 0.75